No AccessJournal of UrologyUROLOGICAL SURVEY: Abstracts1 Jan 2000BENIGN AND MALIGNANT NEOPLASMS OF PROSTATE Patrick C. WalshM.D. Patrick C. WalshPatrick C. Walsh View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)68052-4AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 : Cancer surveillance series: interpreting trends in prostate cancer—part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst1999; 91: 1025. Crossref, Medline, Google Scholar 2 : Cancer surveillance series: interpreting trends in prostate cancer—part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst1999; 91: 1033. Crossref, Medline, Google Scholar 3 : An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. JAMA1993; 269: 2633. Google Scholar 1 : Potency and continence following anatomic radical prostatectomy: patient versus physician reported outcomes. J Urol1999; 161: 387. abstract 1501. Google Scholar 1 : Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med1998; 339: 1036. Crossref, Medline, Google Scholar 1 Cancer risks in BRCA2 mutation carriers. Breast Cancer Linkage Consortium. J Natl Cancer Inst1999; 91: 1310. Google Scholar © 2000 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 163Issue 1January 2000Page: 364-375 Advertisement Copyright & Permissions© 2000 by American Urological Association, Inc.MetricsAuthor Information Patrick C. Walsh More articles by this author Expand All Advertisement PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Patrick C. Walsh (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: